Fundraising FoxGlaia
3 known investors
Find your way into Glaia
Glaia develops technology that improves plant photosynthesis efficiency to increase crop yields without adding more agricultural inputs. The company applies pharmaceutical-grade scientific principles derived from university research to help farmers optimize plant performance in real-world farming systems.
Founders & leadership
DD
Dr David BenitoFounder & Chief Executive Officer
DI
Dr Imke SittelFounder & Chief Scientific Officer
Investors · 3
Green Angel Ventureslisted by Green Angel VenturesLondon
How we know: Green Angel Ventures's portfolio page · Not right? Tell us
The Yield Lab Europelisted by The Yield Lab EuropeDublin · $108K – $2.2M
How we know: The Yield Lab Europe's portfolio page · the VCSheet dataset · Not right? Tell us
The Yield LabreportedSingapore · $48K – $12M
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundMar 2022
Green Angel Syndicate (lead), Yield Lab Europe
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Glaia do?
- Glaia develops technology that improves plant photosynthesis efficiency to increase crop yields without adding more agricultural inputs. The company applies pharmaceutical-grade scientific principles derived from university research to help farmers optimize plant performance in real-world farming systems.
- Who founded Glaia?
- Glaia was founded by Dr David Benito, Dr Imke Sittel.
- Who are Glaia's investors?
- Glaia's investors include Green Angel Ventures, The Yield Lab Europe, The Yield Lab.